Pulmonology

Re-examination revealed that alpha-gal allergy resulted in a change in the identification of definitive anaphylaxis triggers in 25% of cases.

The synthetic vitamin B9 is a common prenatal treatment to prevent birth defects, but may not be as safe as its natural form.

While peanut butter exposure aids children from an early age, fish oil could improve asthma rates.

While the data have been met with conflicting opinions, environmental interventions for allergens in the home hold potential for asthma.

The researcher from Ghent University in Belgium discussed the improved quality of life patient with severe nasal polyps experience with monoclonal antibodies.

Policy interventions and medication are the best available methods for improving the negative impact pollutants have on patients.

Improving asthma management in schools not only benefits pediatric patients' health, but improves attendance rates.

Those with blood type B or AB are an estimated 5-fold less likely to be diagnosed with red meat allergy.

The condition was found to be linked in pediatric patients who already suffer from asthma, atopic dermatitis, or food allergies, and can lead to children developing allergic rhinitis.

New study results compound on previous evidence of an association between tick bites and red meat allergy.

Early allergen sensitization is associated with an increased risk of viral infections and the development of childhood asthma.

Alexia Beauregard, MS, RD, CSP, LD, explains how a food allergy specialist dietitian could make a life-saving difference in helping families understand food allergy.

The FDA previously approved DUPIXENT in the US for the treatment of adults with moderate-to-severe atopic dermatitis.

One week after Vertex Pharmaceuticals Incorporated initiated its first Phase 3 study of VX-659, tezacaftor and ivacaftor regimen for people with cystic fibrosis, the company has announced it is initiating a second.

Spruce Biosciences has announced the launch of the CAH Natural History Study, an initiative to advance knowledge and awareness of congenital adrenal hyperplasia.

A $2.8 million Fast Track Small Business Innovation Research (SBIR) grant has been awarded to PhaseBio Pharmaceuticals from the National Institutes of Health (NIH) to support the clinical development of PB1046 in treating patients with pulmonary arterial hypertension (PAH).

Varicose veins were rarely thought to have severe health effects, but should now be monitored closely, new evidence suggests.